CNS Pharmaceuticals

CNSP · NASDAQ

$4.99−$0.01 (−0.20%)TodayMarket closed ·
Prev close $5.00

Latest news

  • Press releaseACCESS Newswire

    CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releaseACCESS Newswire

    CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • NewsVandana Singh

    What's Going On With CNS Pharmaceuticals Stock On Wednesday?

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • NewsAvi Kapoor

    Gold Falls Over 2%; US Factory Orders Rise In March

  • NewsAvi Kapoor

    Dow Falls Over 150 Points; Tyson Foods Posts Upbeat Earnings

  • NewsVandana Singh

    Nano-Cap CNS Pharmaceuticals Stock Explodes As Capital Raise Fuels Pivot

  • News

    CNS Pharmaceuticals Enters Securities Purchase Agreements For ~$22.5M Private Placement Of 650,000 Shares At $2.30 Per Share And Warrants To Purchase Up To ~9.1M Shares At Purchase Price $2.299 Per Warrant

  • News

    Market-Moving News for May 4th

  • Press releaseACCESS Newswire

    CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • News

    CNS Pharmaceuticals Launches Global Search For Neurology And Oncology Assets, Shifts Focus From Glioblastoma

  • Press releaseACCESS Newswire

    CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline

  • Press releaseACCESS Newswire

    CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team

  • Press releaseACCESS Newswire

    CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releaseACCESS Newswire

    CNS Pharmaceuticals Issues Letter to Shareholders

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • NewsAvi Kapoor

    Why Webtoon Entertainment Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket

  • Press releaseGlobe Newswire

    IBN Announces Latest Episode of The BioMedWire Podcast Featuring John Climaco, CEO of CNS Pharmaceuticals Inc.

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • News

    Market-Moving News for May 13th

  • NewsVandana Singh

    CNS Pharma's Cancer Drug Misses Survival Goal But May Offer Fewer Side Effects

  • NewsAvi Kapoor

    S&P 500 Edges Higher; Analog Devices Earnings Top Views

  • NewsAvi Kapoor

    Dow Dips 150 Points; US Housing Starts Fall In January

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • NewsAvi Kapoor

    Why Tesla Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • NewsAvi Kapoor

    Nasdaq Down 2%; US Crude Stocks Increase

  • NewsAvi Kapoor

    Gold Moves Lower; AT&T Earnings Top Views

  • NewsAvi Kapoor

    Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss

  • NewsAvi Kapoor

    Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket

  • Press releaseGlobe Newswire

    IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc.

  • NewsAvi Kapoor

    Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.